Insights That
Move You Forward
Helping you make smarter decisions, avoid costly missteps, and
bring safe, effective products to market with confidence
What Happens After Clinical Trial Close-Out: Transitioning to Reimbursement
Clinical trial close-out is no longer the end of the development process. In 2026, sponsors must transition quickly from regulatory evidence generation to reimbursement and market access planning. Learn how clinical strategy, real-world evidence, payer expectations, and post-market planning now shape commercialization success for medical devices and combination products.
Large vs. Boutique CRO: Which Is Right For Your Clinical Trial?
Choosing between a large CRO and a boutique CRO can significantly impact clinical trial timelines, budgets, and outcomes. This article explores the strengths and limitations of each model, outlines key questions sponsors should ask during vendor selection, and explains why many medical device and combination product companies benefit from a more specialized, hands-on CRO partnership.
CRO vs. Consulting Firm: What’s the Difference and Why It Matters
Success in clinical development depends on knowing when to engage a CRO and when to rely on a consulting firm. CROs excel at executing trials with precision, while consulting firms guide strategy, submissions, and compliance. Understanding the difference—and when you need both—can mean the difference between costly delays and streamlined market approval.